The Gynecologic Cancer Steering Committee (GCSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult gynecologic cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GCSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-Chairs
Deborah Armstrong, M.D.
Johns Hopkins University
Linda Duska, M.D., M.P.H.
University of Virginia
Anuja Jhingran, M.D.
University of Texas M.D. Anderson Cancer Center
Members
Lisa Barr, MFA
Patient Advocate
Mark S. Carey, M.D.
Vancouver General Hospital
Junzo Paul Chino, M.D.
Duke University
Paul DiSilvestro, M.D.
Women & Infants Hospital of Rhode Island
Don S. Dizon, M.D., FACP
Tufts University School of Medicine
Linda Emery
Patient Advocate
Britt Erickson, M.D.
University of Minnesota
Stephanie L. Gaillard, M.D., Ph.D.
Johns Hopkins University
Kathryn P. Gray, Ph.D.
Harvard Medical School/Boston Children's Hospital
Amelia Jernigan, M.D.
Louisiana State University School of Medicine
Masha Kocherginsky, Ph.D.
Northwestern University
Elise Kohn, M.D.
National Cancer Institute, CTEP
Ursula A. Matulonis, M.D.
Massachusetts General Hospital, Harvard University
Michael Milosevic, M.D., FRCPC
University Health Network-Princess Margaret Cancer Centre
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Katherine Marie Moxley, M.D., M.S.
Oklahoma Cancer Specialists and Research Institute
Carolyn Y. Muller, M.D.
University of New Mexico, Comprehensive Cancer Center
Matthew A. Powell, M.D.
Washington University
Larry V. Rubinstein, Ph.D.
National Cancer Institute Biometric Research Branch
Premal H. Thaker, M.D., M.S.
Washington University, St. Louis
Claire Verschraegen, M.D., M.S.
Ohio State University Comprehensive Cancer Center
Stephen Welch, M.D.
London Regional Cancer Program
David Zahrieh, Ph.D.
Mayo Clinic
NCI CCCT Program Director
Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov